NIBAN2 concentrations in normal human astrocytes (NHAs) and eight glioma cell lines (U‐251, T98G, LN‐229, A‐172, LN‐18, H4, U118MG, and U‐87MG) were quantified by WB. Here, NIBAN2 is linked to central nervous system cancer.